Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
According to previous research, the incidence of necrotising enterocolitis (NEC) decreases after supplementation with probiotics. However, few studies have considered the equivalence or otherwise of different strains of probiotics in this respect. Accordingly, this prospective observational study was conducted in a cohort of 245 very-low-birth-weight (VLBW) new-borns to assess the prevalence of NEC after supplementation with the probiotic Inforan® (Berna Biotech, Madrid, Spain) 250 mg capsules containing 109 cfu of Lactobacillus acidophilus (ATCC 4356) and 109 cfu of Bifidobacterium bifidum (ATCC 15696); or with Bivos® (Ferring, Madrid, Spain) containing Lacticaseibacillus (formerly Lactobacillus) rhamnnosus (LGG) (ATCC 53103) (109 cfu); or with no probiotic supplementation. Statistical analysis was performed using multivariant regression for the duration of parenteral nutrition, length of neonatal intensive care unit stay, use of oxygen therapy and presence of chorioamnionitis. Of the VLBW new-borns in the study group, 65 received Infloran, 108 received Bivos and 72 received no probiotic. A significant association was observed between a reduced presence of NEC Stage ≥2 and probiotic supplementation. The odds risk (OR) obtained was 0.174 (95% confidence interval (CI): 0.032-0.936) for Infloran and 0.196 (95%CI: 0.053-0.732) for Bivos. Therefore, both probiotics are associated with a lower prevalence of NEC in VLBW new-borns, with no significant differences.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
Alfaleh, K. and Anabrees, J., 2014. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews: CD005496. https://doi.org/10.1002/14651858.CD005496.pub4
Baucells, B.J., Mercadal, H.M., Alvarez Sanchez, A.T. and Figueras, A.J., 2016. Probiotic associations in the prevention of necrotising enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1,500g: a systematic review. Anales de Pediatría 85: 247-255. https://doi.org/10.1016/j.anpedi.2015.07.038
Bell, M., Ternberg, J., Feigin, R., Keating, J., Marshall, R., Barton, L. and Brotherton, T., 1978. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 187: 1-7.
'Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging ' () 187 Annals of Surgery : 1 -7.
Bernardo, W.M., Aires, F.T., Carneiro, R.M., Sa, F.P., Rullo, V.E. and Burns, D.A., 2013. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. Journal of Pediatrics 89: 18-24. https://doi.org/10.1016/j.jped.2013.02.004
Ehrenkranz, R.A., Walsh, M.C., Vohr, B.R., Jobe, A.H., Wright, L.L., Fanaroff, A.A., Wrage, L.A. and Poole, K., 2005. Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia. Pediatrics 116: 1353-1360. https://doi.org/10.1542/peds.2005-0249
European Medicines Agency, 2014. Orphan drug designation for Lactobacillus acidophilus and Bifidobacterium bifidum for the prevention of necrotising enterocolitis. EU/3/13/1213. European Medicines Agency, Amsterdam, the Netherlands.
Gewolb, I.H., Schwalbe, R.S., Taciak, V.L., Harrison, T.S. and Panigrahi, P., 1999. Stool microflora in extremely low birthweight infants. Archives of Disease in Childhood: Fetal and Neonatal Edition 80: F167-F173.
'Stool microflora in extremely low birthweight infants ' () 80 Archives of Disease in Childhood: Fetal and Neonatal Edition : F167 -F173.
Hwang, Y.S., Ma, M.C., Tseng, Y.M. and Tsai, W.H., 2013. Associations among perinatal factors and age of achievement of full oral feeding in very preterm infants. Pediatrics and Neonatology 54: 309-314. https://doi.org/10.1016/j.pedneo.2013.03.013
International Committee for the Classification of Retinopathy of Prematurity, 2005. The International Classification of Retinopathy of Prematurity revisited. Archives of Ophthalmology 123: 991-997.
Jacobi, S.K. and Odle, J., 2012. Nutritional factors influencing intestinal health of the neonate. Advances in Nutrition 3: 687-696. https://doi.org/10.3945/an.112.002683
Jobe, A.H. and Bancalari, E., 2001. Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 163: 1723-1729.
'Bronchopulmonary dysplasia ' () 163 American Journal of Respiratory and Critical Care Medicine : 1723 -1729.
Kane, A.F., Bhatia, A.D., Denning, P.W., Shane, A.L. and Patel, R.M., 2018. Routine supplementation of Lactobacillus rhamnosus gg and risk of necrotizing enterocolitis in very low birth weight infants. Journal of Pediatrics 195: 73-79. https://doi.org/10.1016/j.jpeds.2017.11.055
Lad, E.M., Hernandez-Boussard, T., Morton, J.M. and Moshfeghi, D.M., 2009. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. American Journal of Ophthalmology 148: 451-458. https://doi.org/10.1016/j.ajo.2009.04.018
Lin, H.C., Hsu, C.H., Chen, H.L., Chung, M.Y., Hsu, J.F., Lien, R.I., Tsao, L.Y., Chen, C.H. and Su, B.H., 2008. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700. https://doi.org/10.1542/peds.2007-3007
Mahieu, L.M., De Muynck, A.O., De Dooy, J.J., Laroche, S.M. and Van Acker, K.J., 2000. Prediction of nosocomial sepsis in neonates by means of a computer-weighted bedside scoring system (NOSEP score). Critical Care Medicine 28: 2026-2033.
'Prediction of nosocomial sepsis in neonates by means of a computer-weighted bedside scoring system (NOSEP score) ' () 28 Critical Care Medicine : 2026 -2033.
Meyer, M.P. and Alexander, T., 2017. Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin. Journal of Neonatal-Perinatal Medicine 10: 249-255. https://doi.org/10.3233/NPM-16130
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., the PRISMA Group, 2009. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. BMJ 339: b2535. https://doi.org/10.1136/bmj.b2535
Murguia-Peniche, T., Mihatsch, W.A., Zegarra, J., Supapannachart, S., Ding, Z.Y. and Neu, J., 2013. Intestinal mucosal defense system, part 2. Probiotics and prebiotics. Journal of Pediatrics 162: S64-S71. https://doi.org/10.1016/j.jpeds.2012.11.055
Narbona, E., Uberos, J., Armada, M.I., Couce, M.L., Rodriguez, G. and Saenz de Pipaon, M., 2014. Nutrition and Metabolism Group of the Spanish Neonatology Society: recommendations and evidence for dietary supplementation with probiotics in very low birth weight infants. Anales de Pediatría 81: 397-398. https://doi.org/10.1016/j.anpedi.2014.06.020
Oh, N.S., Joung, J.Y., Lee, J.Y. and Kim, Y., 2018. Probiotic and anti-inflammatory potential of Lactobacillus rhamnosus 4B15 and Lactobacillus gasseri 4M13 isolated from infant feces. PLoS ONE 13: e0192021. https://doi.org/10.1371/journal.pone.0192021
Papile, L.A., Burstein, J., Burstein, R. and Koffler, H., 1978. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics 92: 529-534.
'Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm ' () 92 Journal of Pediatrics : 529 -534.
Samuels, N., Van de Graaf, R., Been, J.V., De Jonge, R.C., Hanff, L.M., Wijnen, R.M., Kornelisse, R.F., Reiss, I.K. and Vermeulen, M.J., 2016. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study. Scientific Reports 6: 31643. https://doi.org/10.1038/srep31643
Uberos, J., Aguilera-Rodriguez, E., Jerez-Calero, A., Molina-Oya, M., Molina-Carballo, A. and Narbona-Lopez, E., 2017. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants. British Journal of Nutrition 117: 994-1000. https://doi.org/10.1017/S0007114517000769
Zozaya, C., Garcia Gonzalez, I., Avila-Alvarez, A., Oikonomopoulou, N., Sanchez Tamayo, T., Salguero, E., Saenz de Pipaon, M., Garcia-Muñoz Rodrigo, F. and Couce, M.L., 2020. Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study. Frontiers in Pediatrics 8: 188.
'Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study ' () 8 Frontiers in Pediatrics : 188.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1031 | 303 | 34 |
| Gesamttextansichten | 51 | 13 | 1 |
| PDF-Downloads | 101 | 29 | 3 |
According to previous research, the incidence of necrotising enterocolitis (NEC) decreases after supplementation with probiotics. However, few studies have considered the equivalence or otherwise of different strains of probiotics in this respect. Accordingly, this prospective observational study was conducted in a cohort of 245 very-low-birth-weight (VLBW) new-borns to assess the prevalence of NEC after supplementation with the probiotic Inforan® (Berna Biotech, Madrid, Spain) 250 mg capsules containing 109 cfu of Lactobacillus acidophilus (ATCC 4356) and 109 cfu of Bifidobacterium bifidum (ATCC 15696); or with Bivos® (Ferring, Madrid, Spain) containing Lacticaseibacillus (formerly Lactobacillus) rhamnnosus (LGG) (ATCC 53103) (109 cfu); or with no probiotic supplementation. Statistical analysis was performed using multivariant regression for the duration of parenteral nutrition, length of neonatal intensive care unit stay, use of oxygen therapy and presence of chorioamnionitis. Of the VLBW new-borns in the study group, 65 received Infloran, 108 received Bivos and 72 received no probiotic. A significant association was observed between a reduced presence of NEC Stage ≥2 and probiotic supplementation. The odds risk (OR) obtained was 0.174 (95% confidence interval (CI): 0.032-0.936) for Infloran and 0.196 (95%CI: 0.053-0.732) for Bivos. Therefore, both probiotics are associated with a lower prevalence of NEC in VLBW new-borns, with no significant differences.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1031 | 303 | 34 |
| Gesamttextansichten | 51 | 13 | 1 |
| PDF-Downloads | 101 | 29 | 3 |